Iain McGregor

Academic Director
Lambert Initiative for Cannabinoid Therapeutics
Brain and Mind Centre
University of Sydney
Australia

http://sydney.edu.au/science/people/iain.mcgregor.php

http://sydney.edu.au/science/lambert/

Iain McGregor is Professor of Psychopharmacology and Academic Director of the Lambert Initiative for Cannabinoid Therapeutics in the Brain and Mind Centre at the University of Sydney, Australia.

Iain's research is focused on the discovery and development of new medications for the treatment of disease. Iain has more than 300 peer-reviewed publications and multiple patents. The discoveries of his team around the use of oxytocin-like small molecules to treat addiction and social withdrawal led to the successful spinoff company Kinoxis Therapeutics.

The Lambert Initiative for Cannabinoid Therapeutics which was formed in 2015 with a gift of unprecedented generosity from the Lambert family to the University of Sydney. The Lambert Initiative, under Iain’s leadership, conducts world-leading research into the therapeutic benefits of cannabinoids in epilepsy, pain, cancer, addictions and mental health conditions. In April 2024, Iain received an award from the International Alliance for Cannabinoid Medicines (IACM) for his outstanding clinical research into cannabis and the cannabinoids.

Recently Iain and his team have diversified into psychedelic research and are currently implementing a new research program around plant-based psychedelic drug discovery including a recently-established clinical trial of psilocybin in the treatment of eating disorders.